Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tan A Ince

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivoFiona Simpkins, Pedro Hevia-Paez, Jun Sun, et al.
Cancer Research|March 31, 2011
Differentiation of NUT midline carcinoma by epigenomic reprogrammingBrian E Schwartz, Matthias D Hofer, Madeleine E Lemieux, et al.
Cancer Research|January 9, 2016
Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant ProgressionManuel Picon-Ruiz, Chendong Pan, Katherine Drews-Elger, et al.
Nature Communications|November 17, 2020
Transient commensal clonal interactions can drive tumor metastasisSuha Naffar-Abu Amara, Hendrik J Kuiken, Laura M Selfors, et al.
Nature Communications|June 18, 2015
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumoursTan A Ince, Aurea D Sousa, Michelle A Jones, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivoFiona Simpkins, Pedro Hevia-Paez, Jun Sun, et al.
Cancer Research|March 31, 2011
Differentiation of NUT midline carcinoma by epigenomic reprogrammingBrian E Schwartz, Matthias D Hofer, Madeleine E Lemieux, et al.
Cancer Research|January 9, 2016
Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant ProgressionManuel Picon-Ruiz, Chendong Pan, Katherine Drews-Elger, et al.
Nature Communications|November 17, 2020
Transient commensal clonal interactions can drive tumor metastasisSuha Naffar-Abu Amara, Hendrik J Kuiken, Laura M Selfors, et al.
Nature Communications|June 18, 2015
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumoursTan A Ince, Aurea D Sousa, Michelle A Jones, et al.
Pageof 7